Zynerba Pharmaceuticals Aktie
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
Zynerba Pharmaceuticals Aktie Analyse
| 22.04.19 | Zynerba Pharmaceuticals Buy | Canaccord Adams | |
| 01.02.18 | Zynerba Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 26.01.18 | Zynerba Pharmaceuticals Buy | Seaport Global Securities | |
| 02.10.17 | Zynerba Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 08.08.17 | Zynerba Pharmaceuticals Neutral | H.C. Wainwright & Co. | |
| 07.08.17 | Zynerba Pharmaceuticals Hold | Maxim Group | |
| 07.08.17 | Zynerba Pharmaceuticals Neutral | Cantor Fitzgerald | |
| 28.03.17 | Zynerba Pharmaceuticals Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
| 24.02.17 | Zynerba Pharmaceuticals Buy | Maxim Group | |
| 22.12.16 | Zynerba Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 07.10.16 | Zynerba Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 12.11.15 | Zynerba Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
| 08.09.15 | Zynerba Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
Werbung
Werbung